Company / EPS (Diluted)
Zai Lab Ltd EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.35
FY2025
5-year range
-$3.03 / -$0.35
FY2021-FY2025
Trend
+23.9%
vs FY2024
Sector context
#61 of 204
Health Care
What the data says
At $-0.35, Zai Lab Ltd's eps (diluted) ranks #61 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 6 years, ranging from $-3.03 in FY2021 to $-0.35 in FY2025.
Based on SEC 10-K filings.
-0.35 in FY2025.
Improved from $-0.76 to $-0.35 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 204 in Health CareTop 30% of 204This company -$0.35 Sector average -$0.89
▼
+60.5% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 23.9% year-over-year.
- Ranks #61 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.35 | +23.9% |
| FY2024 | -$0.46 | +39.5% |
| FY2023 | -$0.76 | -117.1% |
| FY2022 | -$0.35 | +88.4% |
| FY2021 | -$3.03 | -14.8% |
| FY2020 | -$2.64 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026